Published: 7 June 2019

Publications

Recent approvals of medicines containing a new active ingredient

Prescriber Update 40(2): 37
June 2019

For the period 16 January 2019 to 15 April 2019.

Trade name
(Active ingredient)
Dose form and strength(s) herapeutic area
Agrylin (anagrelide) Capsule
0.5 mg
Essential thrombocythaemia
Phenasen (arsenic trioxide) Concentration for injection
10 mg/10 mL
Acute promyelocytic leukaemia (APL)


See the Medsafe Product/Application search for more information about these medicines. Data sheets of currently marketed medicines are also available.

0 1 2 4 5 6 7 9 [ /